Review/Advances in Neurological Therapeutics (2015). Immune–mediated central nervous system disorders
2017 Volume 33 Issue 4 Pages 515-517
Details
2017 Volume 33 Issue 4 Pages 515-517
Recent advances and new evidences related to treatment for multiple sclerosis (MS) were reviewed. In year of 2015, glatiramer acetate has been approved in Japan. New biological reagents have been developed in these several years, however, it seems very important to reconsider self injection agents such as interferon beta 1a/1b, or glatiramer acetate. They are still working well and very valuable.
From such point of view manuscripts especially regarding optimization of disease modifying therapy for MS were reviewed.
